FDA recalls ranitidine medicines over potential cancer causing impurity
The US Food and Drug Administration has asked doctors and patients to return certain batches of over-the-counter ranitidine tablets (75 mg and 150 mg), after low levels of the probable human…
Read Original Article: FDA recalls ranitidine medicines over potential cancer causing impurity »
